DreaMed Diabetes has received a CE Mark for its Type 1-focused clinical decision support (CDS) platform, Advisor Pro.
Read more on MobiHealthNews here.
![[Wefox in TechCrunch] Wefox grabs $400M at $4.5B valuation to buck the insurtech downturn trend](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[Wefox in TechCrunch] Wefox grabs $400M at $4.5B valuation to buck the insurtech downturn trend
July 12, 2022
[ReWalk in GlobeNewsWire] ReWalk Robotics announces planned changes to board of directors
July 28, 2023
